Michigan Genetic Hereditary Testing (MiGHT)
Completed · Not applicable
Conditions studied: Breast Cancer, Colorectal Cancer, Ovarian Cancer, Prostate Cancer, Pancreatic Cancer, Endometrial Cancer, History of Cancer
In brief
The primary purpose of this study is to compare three interventions, two experimental and one standard of care (usual care), to see if the experimental interventions will increase the likelihood of a participant obtaining guideline-concordant genetic testing. Eligible participants will be randomized (assigned) to one of the following interventions: 1) Virtual genetics navigator, a mobile-optimized website, designed by the investigators, that delivers tailored messages and content; 2) two motivational interviewing (MI) telephone calls delivered by trained genetics health coaches; or 3) usual care.
Key facts
- Study ID
- NCT05162846
- Run by
- University of Michigan Rogel Cancer Center
- People needed
- 831
- Starts
- 2022-04-21
- Expected to finish
- 2025-11-21
- Last updated by the study team
- 2026-03-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Able to speak and read English
- Access to the internet
- Completed the Family Health History Tool (FHHT)
- Meeting clinical criteria for genetic evaluation due to any of the below:
- Personal history of Breast cancer either:
- i. Diagnosed under 50
- ii. Personal or family history of triple negative breast cancer
- iii. Ashkenazi Jewish ancestry
- iv. Male proband
- v. 1st or 2nd degree relative with ovarian cancer, pancreatic cancer, breast cancer diagnosed under 50, or male breast cancer
- Personal history of prostate cancer either:
- i. Diagnosed under 50
- ii. Ashkenazi Jewish ancestry
- iii. 1st or 2nd degree relative with ovarian cancer, pancreatic cancer, breast cancer diagnosed under 50, or male breast cancer
- Personal history of any cancer or no personal history of cancer with either:
- i. PREMM score ≥ 2.5%
- ii. 1st degree relative with pancreatic, or male breast cancer
- iii. 1st or 2nd degree relative with ovarian cancer
- iv. 1st degree relative with any of these cancers diagnosed under 50: colon, endometrial, or breast
- v. Ashkenazi Jewish ancestry and 1st or 2nd degree relative with breast cancer
- Personal history of endometrial cancer diagnosed under 50
- Personal history of colorectal cancer diagnosed under 50
- Personal history of renal cancer diagnosed under 46
- Personal history of sarcoma diagnosed under 46 and a 1st or 2nd degree relative with sarcoma, breast cancer, or brain cancer diagnosed under 56
- Personal history of brain cancer diagnosed under 46 and a 1st or 2nd degree relative with sarcoma, breast cancer, or brain cancer diagnosed under 56
You may not qualify if…
- Prior clinical germline genetic testing for cancer or already have an upcoming appointment scheduled with a genetics provider
Where it is running
- University of Michigan Rogel Cancer Center — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.